Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Triamcinolone Acetonide vs Laser Photocoagulation for Diabetic Macular Edema
NCT00367133Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jul 2004
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triamcinolone in diabetic macular edema (DME) (3 arms), sponsored by Jaeb Center for Health Research. Primary endpoints: Change In Visual Acuity [Measured With Electronic-Early Treatment Diabetic Retinopathy Study (E-ETDRS)] at 2 years, Median Change in Visual Acuity at 2 years and 1 more. Started Jul 2004; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00367133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367133.